Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Liver cirrhosis.

Pinzani M, Rosselli M, Zuckermann M.

Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):281-90. doi: 10.1016/j.bpg.2011.02.009. Review.

PMID:
21497745
2.

Hepatic venous pressure gradient and outcomes in cirrhosis.

Ripoll C.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S330-5. Review.

PMID:
17975485
3.

Pathophysiology and a Rational Basis of Therapy.

Gracia-Sancho J, Maeso-Díaz R, Bosch J.

Dig Dis. 2015;33(4):508-14. doi: 10.1159/000374099. Epub 2015 Jul 6.

PMID:
26159267
4.

Angiogenesis in chronic liver disease and its complications.

Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H.

Liver Int. 2011 Feb;31(2):146-62. doi: 10.1111/j.1478-3231.2010.02369.x. Epub 2010 Nov 15. Review.

PMID:
21073649
5.

Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.

Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, Mela M, Manousou P, Senzolo M, Dhillon AP, Patch D, Burroughs AK.

Liver Transpl. 2007 Sep;13(9):1305-11.

7.

Complications of cirrhosis. I. Portal hypertension.

Bosch J, García-Pagán JC.

J Hepatol. 2000;32(1 Suppl):141-56. Review.

PMID:
10728801
8.

Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis.

Kim MY, Baik SK, Yea CJ, Lee IY, Kim HJ, Park KW, Kim HK, Suk KT, Kim JW, Kim HS, Kwon SO, Cha SH, Kim YJ, Koh SB, Chang SJ.

Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1241-6. doi: 10.1097/MEG.0b013e32832a21c1.

PMID:
19455045
9.

Angiogenesis in liver disease.

Fernández M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J.

J Hepatol. 2009 Mar;50(3):604-20. doi: 10.1016/j.jhep.2008.12.011. Epub 2008 Dec 31. Review.

10.
11.

[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].

Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.

Korean J Hepatol. 2008 Jun;14(2):150-8. doi: 10.3350/kjhep.2008.14.2.150. Korean.

PMID:
18617762
12.

[Pathology of liver cirrhosis and portal hypertension].

Bläker H, Theuer D, Otto HF.

Radiologe. 2001 Oct;41(10):833-9. Review. German.

PMID:
11715574
13.

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.

Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M.

J Viral Hepat. 2010 Jun;17(6):400-9. doi: 10.1111/j.1365-2893.2009.01197.x. Epub 2009 Sep 15.

PMID:
19780945
14.

Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.

Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program.

Am J Gastroenterol. 2009 Jul;104(7):1802-29. doi: 10.1038/ajg.2009.191. Epub 2009 May 19. Review. Erratum in: Am J Gastroenterol. 2009 Jul;104(7):1894. Lim, Joseph [corrected to Lim, Joseph K].

PMID:
19455106
15.

Liver fibrosis: from the bench to clinical targets.

Pinzani M, Rombouts K.

Dig Liver Dis. 2004 Apr;36(4):231-42. Review. Erratum in: Dig Liver Dis. 2004 Aug;36(8):562-3.

PMID:
15115333
16.

[Cirrhosis].

Hillaire S, Voitot H.

Pathol Biol (Paris). 1999 Nov;47(9):895-902. Review. French.

PMID:
10609269
17.

A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.

Spahr L, Giostra E, Frossard JL, Morard I, Mentha G, Hadengue A.

Am J Gastroenterol. 2007 Jul;102(7):1397-405. Epub 2007 May 3.

PMID:
17488248
18.

Etiology, natural history and treatment of hepatocellular carcinoma.

Colombo M, Sangiovanni A.

Antiviral Res. 2003 Oct;60(2):145-50. Review.

PMID:
14638411
19.

[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].

Gentilini P, Laffi G, La Villa G, Casini-Raggi V, Romanelli RG, Buzzelli G, Mazzanti R, Marra F, Pinzani M, Zignego AL.

Ann Ital Med Int. 1996 Oct;11 Suppl 2:23S-29S. Italian.

PMID:
9004817
20.

Supplemental Content

Support Center